title: Internal assessment of a novel islet isolation facility in Spain.
abstract: Islet transplantation is a promising therapy in the treatment of diabetes mellitus. Herein we present the result from the first series of islet isolations carried out in our new islet isolation facility. The aims of study were to analyze the influence of various donor characteristics on the success of islet isolation and compare these outcomes with other European and American groups. Data from 22 completed islet isolation were used to compare donor and isolation variables among successful (>300,000 IEQs) versus unsuccessful isolations. The successful isolation rate from our laboratory was 31.8%. We did not see any significant differences between successful and unsuccessful groups according to donor characteristics, although age was close to significance (38.57 +/- 10.29 versus 48.33 +/- 12.39; P = .08). Donor age (1.12 [1.23; 0.99]) and body mass index (0.065 [1.32; 3.08]) were associated with isolation success in a logistic regression model. We did not find differences among intraprocedure variables with the exception of IEQ prepurification (409,073 +/- 115,041 versus 263,776 +/- 128,988; P < .05). IEQpre and IEQpost were positively correlated (P < .05). In comparison with other groups, we observed differences in some cases related to islet yield prepurification (P < .05) but not postpurification. Purity from our islet preparations was the highest from all considered groups (P < .05). Recovery was similar in all groups.
  
  
  CONCLUSIONS
  In our experience, donor characteristics have no influence on the success rate. The digestion step is a critical factor for success. Our results with respect to IE yield were close to that of experienced groups.
authors.affiliation: Endocrinology and Metabolism Department and Human Pancreatic Islet Laboratory, Carlos Haya University Hospital and IMABIS Foundation, Avda. Carlos Haya s/n, Pabellon A, 29010 Malaga, Spain. antoniol.cuesta.exts@juntadeandalucia.es
authors.forename: A L
authors.initials: AL
authors.lastname: Cuesta-Munoz
authors.forename: R M
authors.initials: RM
authors.lastname: Briones
authors.forename: J M
authors.initials: JM
authors.lastname: Mellado-Gil
authors.forename: J M
authors.initials: JM
authors.lastname: Miranda
authors.forename: M J
authors.initials: MJ
authors.lastname: Castro
authors.forename: A
authors.initials: A
authors.lastname: Navarro
authors.forename: S
authors.initials: S
authors.lastname: Ruiz de Adana
authors.forename: A
authors.initials: A
authors.lastname: Alonso
authors.forename: M
authors.initials: M
authors.lastname: Gonzalez-Molina
authors.forename: B
authors.initials: B
authors.lastname: Soria
mesh_terms: D000328:Adult; D015992:Body Mass Index; D002102:Cadaver; D002469:Cell Separation / Q000379:methods; D006801:Humans; D007515:Islets of Langerhans / Q000166:cytology*; D008875:Middle Aged; D012044:Regression Analysis; D013030:Spain; D014019:Tissue Donors; D020858:Tissue and Organ Harvesting / Q000379:methods / Q000592:standards*